We're proud to be partnering with and co-locating our 2026 event with the International Society for Research on Psychedelics Biennial Conference, taking place in New Orleans on February 27-30, 2026.
The 6th Annual Psychedelic Therapeutics & Drug Development Conference
Welcome to our 2026 Event!
The 6th Annual Psychedelic Therapeutics and Drug Development Conference is coming to New Orleans, LA on February 26-27, 2026. This event has been organized to bring together the world’s leading researchers and leaders in academia, industry, the non-profit sector and government to discuss the challenges and opportunities facing those engaged in the research and development of psychedelics for various health conditions with considerable unmet need. This event will highlight the progress being made towards regulatory approval of a variety of psychedelics with the potential to treat various conditions, including inflammatory/autoimmune disorders, brain injury, pain, PTSD, anxiety, ADHD, headaches, depression, and opioid use disorder.
Our speakers and panelists will be covering important topics such as Clinical Trial Design, Intellectual Property, Regulatory Guidance, Psychedelic Drug Delivery, Commercialization, Legal Issues, Emerging Preclinical Science, and New Clinical Data among other topics. This event has been designed and curated for the benefit of key stakeholders in this burgeoning area and will provide practical guidance, discussion and networking.
Why Attend
Network & Re-Connect
Meet and interact with leading scientists, clinicians, and industry professionals in the field of psychedelic research. Utilize our mobile & web-based platforms to set up meetings & connect with colleagues before, during and after the event.
Discover, Learn & Understand
Hear about the latest studies, clinical trials, and advancements directly from the researchers involved. Understanding where the field is headed can help in planning future research, treatment approaches, or business strategies.
Meet Leading Service Providers
Discover innovative tools, technologies, and methodologies being developed to advance psychedelic research and therapy. Explore new products and services offered by companies in the psychedelic research space.
Conference Themes
- Clinical trial design
- Academic findings and research progress updates
- Navigating legal challenges in research
- Targets for novel drug development
- Fundraising for psychedelic drug programs
- Psychedelic drug design
- Psychedelics beyond mental health treatment
- Biomarkers in psychedelic research
- Rescheduling and access
- Research tools and endpoints for psychedelic trials
- Regulatory challenges & guidance
- Toxicology studies and considerations
- Due diligence in psychedelic clinical trial planning
- Neuroimaging psychedelic therapeutic use
- Reimbursement strategies and access
- Psychedelic patents and the IP landscape
- Optimizing psychedelic clinical trials
- Industry clinical trial data sharing
- Psychedelic manufacturing issues/challenges
- The science of psychedelics
Past Featured Speakers
PurMinds Neuropharma
Univ. of Alabama Birmingham
DemeRx
LSU Health Sciences Center
Hebrew University
Gilgamesh Pharmaceuticals
Columbia University
Reunion Neuroscience
MindMed
Psymed Ventures
UC San Francisco
Lykos Therapeutics
Palo Santo
Tactogen
Stanford University
Become a
SPONSOR/EXHIBITOR
As clinical development continues to progress in this revived field of scientific inquiry, developers of new psychedelic-based therapies are in need of partners in the following areas:
- Clinical trial services from Contract Research Organizations (CROs)
- Manufacturing and formulation of new therapies
- Preclinical research services, including: mechanistic studies, safety pharmacology, biomarkers and pharmacokinetics
- Technology companies providing AI and predictive biomarker services
Past Sponsors & Exhibitors
Past sponsors and exhibitors come from the areas of preclinical research, clinical research, chemical manufacturing for R&D, lab equipment & instrumentation, drug manufacturing, specialist chemistry services, data engines & AI modeling, pharma consulting, surveillance tools for safety & effictiveness.
Conference Testimonials
Past Attendees
Who Should Attend
Chief Executive Officers
Vice Presidents
Chief Medical Officers
Business Development Professionals
Regulatory Affairs Professionals
Research Scientists
R&D Professionals
Clinical Development Professionals
Sales Specialists
Government Affairs Professionals
Attorneys/Counsel
Chief Innovation Officers
Presidents
Licensing Professionals
Investigators
Medicinal Chemists
Chemists
Pharmacists
Scientists
Study Managers
Project Managers
Undergraduate Students
Market Access Professionals
Medical Affairs Professionals
Consultants
Chief Operating Officers
Scientific Officers
Professors
Ph.D./Pharm.D. Students
Health Care Practitioners
Program Officers
Investors
Analysts
Medical Directors
Physicians
Scientific Advisors
Founders
Program Managers
Postdoctoral Fellows
